IL-6–dependent neuroimmune signalling is a key contributor to neuronal hyperexcitability and seizures in HSV encephalitis

When the brain is under attack by a virus, the body's immune system rushes to the scene to fight the invader. This response is usually a good thing, but sometimes the very chemicals released to clear the infection can accidentally turn the brain's electrical system into a chaotic storm. In a condition called herpes simplex encephalitis, a common virus that causes cold sores travels to the brain and triggers severe inflammation. For many patients who survive the initial infection, the most dangerous immediate threat is not the virus itself, but the seizures that follow. These seizures happen because brain cells become hyperactive, firing electrical signals uncontrollably, often leading to permanent damage or death. While doctors have long known that inflammation plays a role in these seizures, the specific chain of events that turns a calm brain cell into a frantic one has remained a mystery. Understanding this mechanism is critical because if scientists can pinpoint the exact chemical switch that flips the brain into overdrive, they might be able to stop the seizures before they cause irreversible harm.

A team of researchers at the University of Liverpool and their colleagues have now traced this pathway, identifying a specific immune signal as the primary culprit behind the electrical chaos. Using a sophisticated laboratory model that grows human brain cells from stem cells, the scientists watched what happened when they introduced the herpes virus. They found that within hours of infection, the brain cells began to fire electrical signals much more frequently and in a synchronized, chaotic pattern, even before the cells started to die. This early surge in activity suggested that the virus was not just killing cells, but actively rewiring how they communicated. To find the cause, the researchers looked at the soup of chemicals surrounding the infected cells and discovered a strong link between the level of a specific immune messenger, called interleukin-6, and the intensity of the electrical storms.

The study confirmed that this messenger, interleukin-6, was not just a bystander but a driver of the problem. When the researchers added extra interleukin-6 to healthy brain cells, those cells immediately began to fire erratically, mimicking the seizures seen in patients. Conversely, when they blocked the cells' ability to receive this signal, the chaotic firing stopped. This was true even when the cells were infected with the virus; blocking the signal prevented the hyperactivity, suggesting that the immune response itself was the trigger for the seizures. The researchers also looked at the genetic instructions inside the infected cells and found that the virus caused them to lower the production of a specific protein that normally acts as a brake on electrical activity. This braking mechanism failed because the immune signal interfered with the cell's ability to maintain it.

To ensure these findings applied to real patients, the team examined fluid samples from people who had been hospitalized with the brain infection. They found that patients who experienced seizures had significantly higher levels of this same immune messenger in their spinal fluid compared to those who did not. The researchers also tested their theory in a mouse model of the disease, where they confirmed that the brain cells themselves were producing the signal and becoming more sensitive to it during the infection. The work suggests a clear sequence of events: the virus infects the brain, the brain cells release a warning signal, and that signal accidentally removes the brakes on the brain's electrical system, leading to seizures.

Perhaps most importantly, the study points to a potential way to intervene. The researchers tested a drug that blocks the receptor for this immune messenger, a treatment already used in humans for other conditions. When they gave this blocker to the infected brain cells, it successfully prevented the seizures from starting, even though the virus was still present and the cells were still dying. This indicates that the seizures are a separate, treatable problem driven by the body's own defense system, rather than an unavoidable consequence of the viral infection itself. While more research is needed to see if this approach works in human patients, the study provides a concrete target for new therapies. Instead of just fighting the virus, doctors might one day be able to calm the immune system's overreaction, keeping the brain's electrical signals steady and preventing the devastating seizures that often follow this infection.